Invention Grant
- Patent Title: FMDV and E2 fusion proteins and uses thereof
-
Application No.: US15888718Application Date: 2018-02-05
-
Publication No.: US10363300B2Publication Date: 2019-07-30
- Inventor: Jean-Christophe Audonnet , Frédéric Reynard , Natalia Bomchil , Cécile Sigoillot-Claude
- Applicant: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
- Applicant Address: US GA Duluth
- Assignee: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
- Current Assignee: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
- Current Assignee Address: US GA Duluth
- Agent Judy Jarecki-Black; Suzanne Shope
- Main IPC: A61K39/12
- IPC: A61K39/12 ; A61K39/00 ; A61K39/135 ; C07K14/005 ; C12N7/00 ; A61K39/385 ; C07K14/32
Abstract:
The present invention encompasses FMDV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing FMDV antigens. The invention also encompasses recombinant vectors encoding and expressing FMDV antigens, epitopes or immunogens which can be used to protect animals, in particular ovines, bovines, caprines, or swines, against FMDV. The invention further encompasses methods of making or producing antigenic polypeptides or antigens.
Public/Granted literature
- US20180169216A1 FMDV and E2 Fusion Proteins and Uses Thereof Public/Granted day:2018-06-21
Information query
